EastPharma Ltd. reported consolidated earnings results for the six months ended June 30, 2018. For the six months, the company reported revenue in was USD 132.1 million, up 16.1% from the same period in 2017 USD 113.8 million. EBITDA in 2018 was USD 38.5 million against USD 27.6 million in first half of 2017 representing an EBITDA margin of 29.1% vs 24.3% in first half of 2017.